Reviews in Analgesia : (formerly Analgesia)

Editor: Robert B. Raffa, Ph.D.

ISSN: 1542-961X; E-ISSN: 1555-3876

Softbound

Aims & Scope

Reviews in Analgesia (formerly Analgesia) is an international journal that publishes in English original reviews by experts on topics related to the basic mechanisms and therapeutics of pain relief. Reviews are invited that focus on pain mechanisms, endogenous mediators of pain, mechanisms of analgesia, and the synthesis, testing, or mechanism of action study of known or experimental analgesic compounds-including nonanalgesic and side effect endpoints and abuse liability. In addition, reviews of clinical studies or practice are invited that help elucidate the mechanism of action of known analgesic drugs, or that report on the use of experimental compounds or combinations. Reviews on new or standard methodological approaches, statistical analyses, and theoretical or mathematical treatments are also invited.

EDITOR-IN-CHIEF 

Robert B. Raffa, Ph.D.

EDITORIAL OFFICE ADDRESS
Temple University, School of Pharmacy
3307 North Broad Street
Philadelphia, PA 19140 USA
Phone: 215-707-5227; Fax: 215-707-5228

ADMINISTRATIVE EDITOR
Jeanne E. Coughlin

EDITORIAL BOARD

Keith Budd, Dept. of Anesthetics, Royal Infirmary, Duckworth Lane, Bradford BD9 6RJ, UK
Geoffrey D. Clarke, SmithKline Beecham Consumer Healthcare, Research & Development, St. George's Ave., Weybridge, Surrey, KT13 ODE, UK
Stephen A. Cooper, Whithall Robbins, Inc., Five Giralda Farms, Madison, NJ 17940 USA
Alan Cowan, Dept. of Pharmacology, Temple Univ. School of Medicine, 3420 N. Broad St., Philadelphia, PA 19140-5014 USA
Javier Garzón, Neuropharmacology, Dept. of Neuroanatomy and Cellular Biology, Dr Arce 37, E-28002 Madrid, Spain
Raymond G. Hill, Merck Sharpe and Dohme, Res. Lab/Neuroscience Center, Terlings Park Eastwick Road, Essex CM20 2QR, UK
John C. Hunter, Schering Plough, 2015 Galloping Hil Road, Kenilworth, NJ, 07033 USA
Henry I. Jacoby, Discovery Research, 4119 Ocean Avenue, Brigantine, NJ 08203 USA
Donald R. Jasinski, Center for Chemical Dependence, Johns Hopkins Bayview Medical Ctr., 4940 Eastern Ave., MFL Bldg. 1403, Baltimore, MD 21224-2780 USA
Edward S. Kimball, The R. W. Johnson Pharmaceutical Research Institute, Welsh & McKean Roads, Spring House, PA 19477-0076 USA
Mark J. Millan, Dept. of Neurobiology, Fondax Group de Recherche, 7 Rue Ampere, Puteaux, France
Gavril W. Pasternak, Dept. of Neurology, Memorial Sloan Kettering Cancer Ctr., 1275 York Ave., New York, NY 10021-6007 USA
Sandra C. Roerig, Dept. of Pharmacology, LSU Medical Center, 1501 Kings Highway, Shreveport, LA 71130-3932 USA
Richard B. Rothman, Clinical Psychopharmacology Section, NIDA Addition Research Center, 4940 Eastern Ave., Bldg. C, Baltimore, MD 21224-2735 USA
William K. Schmidt, Adolor Corp., 395 Phoenixville Pike, Malvern, PA 19355 USA
Ronald J. Tallarida, Dept. of Pharmacology, Temple Univ. School of Medicine, 3420 N. Broad Street, Philadelphia, PA 19140-5104 USA
Joseph G. Wettstein, Institut de Recherche Joveinal, 3-9 Rue de al Loge, Fresnes, Cedex, France 94265
James H. Woods, Dept. of Pharmacology, Univ. of Michigan Medical School, 1301 Medical Science Research Bldg. III, Ann Arbor, MI 48109-0632 USA

Volumes 7-8

Author Index

Basbaum, A. I., 39 (v8)
Bassi, N., 97 (v7)
Benedetti, F., 129 (v7)
Budd, K., 1 (v8)

Chapman, V., 25 (v7)
Cohen, A. R., 97 (v7)
Colloca, L., 129 (v7)

Desai, S., 97 (v7)
Dubner, R., 57 (v8)

Espinosa, M. G., 97 (v7)

Farquhar-Smith, W. P., 103 (v8)
Farrell, M., 23 (v8)
Finn, D. P., 25 (v7)
Flynn, E. E., 97 (v7)
Franchetti, K. E., 97 (v7)

Garzón, J., 41 (v7)
Gibson, S. J., 23 (v8)
Guan, Y., 57 (v8)
Guo, W., 57 (v8)

Jarvis, M. F., 1 (v7)

Kuriakose, A., 97 (v7)

Lam, S.-K. T., 97 (v7)
Liu, X. J., 145 (v7)
Ly, K. S., 97 (v7)

Malmberg, A. B., 119 (v7)
McGraw, M. J., 97 (v7)

Namazi, N. N., 97 (v7)
Nemeh, G. A., 97 (v7)

Oliva, C. D., 97 (v7)

Pastakia, S. D., 97 (v7)

Raffa, R. B., 97 (v7), 71 (v8)
Rasmussen, K. G., 61 (v7)
Ren, K., 57 (v8)
Renn, C. L., 57 (v8)
Riley, K. M., 97 (v7)
Rothman, R. B., 83 (v7)

Sánchez-Blázquez, P., 41 (v7)
Sawynok, J., 145 (v7)
Sessle, B. J., 85 (v8)
Stevens, C. W., 69 (v7)

Tairu, O. A., 97 (v7)
Traynor, J. R., 11 (v8)

Xu, H., 83 (v7)

Zeitz, K. P., 119 (v7)

Subject Index

Acute responses, 145 (v7)
Adenosine, 1 (v7)
Age-related differences, 23 (v8)
AMPA, 57 (v8)
Amphibians, 69 (v7)
Analgesia, 97, v7), 71 (v8)
Antinociception, 97 (v7)
Antinociceptive effects, 25 (v7)
ATP, 1 (v7)

Behavior, 11 (v8)

Cannabinoid agonists, 25 (v7)
Cannabinoids, 25 (v7)
Central sensitization, 119 (v7), 145 (v7), 85 (v8)
Chronic pain, 1 (v7), 61 (v7), 85 (v8)

Dependence, 83 (v7)
Descending modulation, 57 (v8)

Efficacy, 11 (v8)
Electroconvulsive therapy, 61 (v7)
Endocannabinoids, 25 (v7), 103 (v8)
Endogenous pain modulation, 129 (v7)

Formalin test, 145 (v7)

GluR1, 57 (v8)
G-protein, 11 (v8)
G-protein signaling, 41 (v7)
[35S]GTP-g-S, 83 (v7)
 

Hyperalgesia, 57 (v8)

Immune system, 1 (v8)
Immunomodulation, 103 (v8)
Immunosuppression, 1 (v8)
Inflammation, 57 (v8)
Injury, 119 (v7)

Kinase, 119 (v7)

Long-term responses, 145 (v7)

Mast cell, 103 (v8)
Molecular structure/function relationship, 1 (v8)
Morphine, 83 (v7)
Mu-opioids, 11 (v8)

Neurobiologic mechanisms, 61 (v7)
Neurophils, 103 (v8)
Nocebo effect, 129 (v7)
Nociceptive signaling, 1 (v7)

Opioid, 97 (v7)
Opioid analgesia, 41 (v7), 69 (v7), 1 (v8)
Opioid receptors, 69 (v7)
Opioid system, 129 (v7)
Orofacial pain, 85 (v8)

Pain, 1 (v8)
Pain model, 145 (v7)
Pain perception, 23 (v8)
Pain relief, 71 (v8)
Pain treatment, 71 (v8)
Patent, 71 (v8)
Peripheral afferent neural activity, 145 (v7)
Peripheral sensitization, 119 (v7)
Persistent pain, 119 (v7)
Phase activity, 145 (v7)
Phosphoserine 831 GluR1, 57 (v8)
Placebo-controlled trials, 129 (v7)
Placebo effect, 129 (v7)
Plants, 97 (v7)
Potency, 11 (v8)
Preclinical tests, 97 (v7)
Primary depression syndrome, 61 (v7)
Primary pain syndrome, 61 (v7)
Psychosocial context, 129 (v7)
Purinergic modulation, 1 (v7)

Rana pipiens, 69 (v7)
Receptor-mediated analgesia, 25 (v7)
RGS proteins, 41 (v7)
Rostral ventromedial medulla, 57 (v8)

Signaling regulation, 41 (v7)

Therapeutic potential, 25 (v7)
Therapist-patient interaction, 129 (v7)
Tolerance, 83 (v7)
Treatment strategies, 23 (v8)
Trigeminal nociceptive pathways, 85 (v8)


Volume 9

Author Index

Abbadie, C., 71

Baron, R., 71
Bender, J. L., 21

Ellrich, J., 1

Fleetwood-Walker, S. M., 71
Fukuoka, T., 31

Garry, E. M., 71

Jadad, A. R., 21
Johnson, R. W., 71

Kobayashi, K., 31

Noguchi, K., 31

Obata, K., 31

Schug, S. A., 45
Sommer, C., 87
Sterling, M., 105

Tan, T. Y., 45

Üçeyler, N., 87

Vanegas, H., 55

Wasner, G., 71

Zhang, J., 13

Subject Index

Acetaminophen (paracetamol), 45
Analgesics, 71

Blink reflex, 1
Brain stem, 1

Chemokine, 13
Chronic pain development, 105
Communication, 21
COX-2 inhibitors (Coxibs), 45
Cytokines, 87

Descending pain control system, 55

Epidemiology, 71
Epidural analgesia, 45
Evidence, 21
 

Headache, 1
Herpes zoster, 71
Hyperalgesia, 31, 55

Inflammation, 55
Interleukins, 87
Internet, 21

Laser, 1

Mechanisms, 71
Monocyte/macrophage recruitment, 13

Neuron-glial interaction, 13
Neuropathic pain, 13, 55, 87
NGF, 31
Nociception, 1
Nonsteroidal anti-inflammatory drugs (NSAIDs), 45
Noxious cold, 31

Orofacial, 1

Pain, 21
Patient-controlled analgesia (PCA), 45
Periaqueductal gray, 55
Postherpetic neuralgia, 71
Postoperative pain, 45
Primary afferent neurons, 31
Psychological stress, 105

Rostral ventromedial medulla, 55

Safety, 45
Sensory hypersensitivity, 105

Treatment, 71
TRPA1, 31
TRPM8, 31
Tumor necrosis factor-\GK\a, 87

Vaccination, 71

Whiplash, 105

Full text articles available: CLICK HERE>

Complete back volumes of this journal are available.

Volumes 7-9: $300 per volume. Please contact publisher directly to order by phone, fax or mail.

Cognizant Communication Corporation
P.O. Box 37
Putnam Valley, NY  10579  U.S.A.
Phone: (845) 603-6440
Fax: (845) 603-6442

Download the Journal Order Form>